Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study-Reference-Cited by-同舟云学术

Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

Published:2012-10-11 Issue:3 Volume:15 Page:204-212
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Nauck M.¹,Frid A.²,Hermansen K.³,Thomsen A. B.⁴,During M.⁴,Shah N.⁵,Tankova T.⁶,Mitha I.⁷,Matthews D. R.⁸

Affiliation:

1. Diabeteszentrum Bad Lauterberg; Bad Lauterberg im Harz; Bad Lauterberg; Germany

2. Clinic of Endocrinology; Skane University Hospital; Malmö; Sweden

3. Department of Endocrinology and Metabolism, Aarhus University Hospital; Aarhus; Denmark

4. Novo Nordisk; Søborg; Denmark

5. Seth G.S. Medical College and KEM Hospital; Mumbai; India

6. Clinical Centre of Endocrinology; Medical University; Sofia; Bulgaria

7. Benmed Hospital; Benoni; South Africa

8. Oxford Centre for Diabetes Endocrinology and Metabolism; NIHR Biomedical Centre; Oxford; UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12012/fullpdf

Reference14 articles.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetologia,2012

2. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control;Rodbard;Endocr Pract,2009

3. http://www.nice.org.uk/nicemedia/live/12165/44318/44318.pdf

4. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in patients with type 2 diabetes (LEAD-1 SU);Marre;Diabet Med,2009

5. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study;Nauck;Diabetes Care,2009

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Retinopathy at a Tertiary Care Center;Ophthalmology Science;2024-11

2. Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis;Pharmaceuticals;2024-07-05

3. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians;Annals of Internal Medicine;2024-05

4. Metformin-Induced Chronic Diarrhea Misdiagnosed as Irritable Bowel Syndrome for Years;Cureus;2024-03-24

5. Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes;Clinical Nutrition ESPEN;2024-02